Bosch Packaging Technology has reported a stable business development for the past fiscal year. With 1.3 billion euros and 6300 associates, the most important corporate figures of 2017 were on a par with the previous year's level, as Uwe Harbauer, Managing Director of the Bosch subsidiary, announced at Achema 2018, the leading global trade show for the processing industry. A higher order volume was achieved in the pharmaceutical sector.
Uwe Harbauer
"The market is continuing to develop positively, and we were able to win market shares in several segments," explanined Harbauer, who is also head of the business unit pharma.
The company expects a good sales development for the pharma division in 2018. In comparison, the food business unit could not entirely match the results of the previous year.
"We have introduced individual restructuring measures to concentrate our activities and optimise our competitiveness," Harbauer said.
The developments in China are highly satisfactory for the business unit pharma: despite growing competition, Bosch was able to further expand business in the region. This is, among others, due to the establishment of an own organization in 2001, which today has nearly 350 employees.
This way Bosch managed to build an extensive customer base at an early stage. Middle East and Africa also saw some forward-looking projects – both in equipping new manufacturing facilities and in expanding existing ones.
The order intake was doubled compared to the previous year.
